Ulrike Baum
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Feasibility of conducting brand-specific influenza vaccine effectiveness studies in three Nordic countries, Denmark, Finland, Sweden.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: February 27, 2026
Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: a target trial emulation study based on registry data.
Journal: The Lancet regional health. Europe
Published: July 18, 2025
Influenza Epidemiology in Finland During and After the COVID-19 Pandemic: Surveillance Data Analysis (2019-2024).
Journal: Influenza and other respiratory viruses
Published: October 30, 2024
Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: September 13, 2024
Non-COVID-19 hospitalisation as a negative control outcome in COVID-19 vaccine effectiveness studies.
Journal: The Lancet. Infectious diseases
Published: January 30, 2024
Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study.
Journal: The Journal of infectious diseases
Published: November 06, 2023
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study.
Journal: BMJ (Clinical research ed.)
Published: July 25, 2023
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
Journal: BMJ (Clinical research ed.)
Published: July 24, 2023
Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
Journal: Frontiers in public health
Published: March 28, 2023
Dawn of the hybrid immunity era in long-term care facilities.
Journal: The lancet. Healthy longevity
Published: July 11, 2022
Last Updated: 09/26/2026